GE News 26.67 05/19/2014 05:00:10 General Electric Company (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
General Electric Company (GE) 26.67 $GE

Stop Ignoring Wearable Tech, It's Already Here
Chris Neiger, The Motley Fool - Motley Fool - Sun May 18, 11:00AM CDT
Samsung's current lineup of smartwatches. Source: Samsung. Let's do a few quick predictions, just for fun. In the future, rescue robots will drive their own vehicles and clear debris for us, people will be able to control prosthetic limbs with...

General Electric Wants Technology to Fuel Energy Innovation
Matt DiLallo, The Motley Fool - Motley Fool - Sun May 18, 9:08AM CDT
Photo credit: General Electric   General Electric sees technology being the key to unlocking more of the world's oil and gas resources, and it's out to prove that by partnering with some of the industry's best energy companies to drive...

Dow 39,000
Dan Dzombak, The Motley Fool - Motley Fool - Sat May 17, 8:00AM CDT
The stocks that make up the Dow Jones Industrial Average are intended to serve as a reflection of the overall stock market and the U.S. economy. But in the first four decades of the Dow's existence, the committee that chose the stocks acted like a...

Will General Electric Company's Bid for Alstom Spur More Takeover Activity in the Industrial Sector?
Lee Samaha, The Motley Fool - Motley Fool - Sat May 17, 7:01AM CDT
The questions that most industrial sector followers must be asking themselves about General Electric Company 's intended purchase of Alstom 's energy business, are whether it will kick-start a prolonged bout of takeover activity in the...

Most active New York Stock Exchange-traded stocks
AP - Fri May 16, 5:06PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Tools and Appliances companies
AP - Fri May 16, 5:05PM CDT
NEW YORK (AP) — Shares of some top tools and appliances companies were up at the close of trading:

How Will General Electric (GE) Stock Be Affected As Company Fights To Save Alstom Deal?
at The Street - Fri May 16, 2:23PM CDT
General Electric (GE) sent one of its top executives to Paris on Friday in an attempt to salvage the $17 billion deal to purchase Alstom

General Electric Exec Goes to France to Promote Alstom Deal and General Motors Fined Maximum Amount
Daniel Miller, The Motley Fool - Motley Fool - Fri May 16, 2:01PM CDT
Stocks were starting to gain ground by midafternoon after yesterday's sell-off, with the Dow Jones Industrial Average  trading 28 points higher, or 0.17%, following positive news from the housing industry. Housing starts rose 13.2% in April, which...

Dow 30 Stock Roundup: Cisco Beats, Wal-Mart Misses - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri May 16, 12:38PM CDT
The sell-off in small cap stocks combined with disappointing earnings from Wal-Mart Stores Inc. (WMT) to push the Dow down to its biggest drop since April 10.

Middday Glance: Tools and Appliances companies
AP - Fri May 16, 12:33PM CDT
NEW YORK (AP) — Shares of some top tools and appliances companies are mixed at 1 p.m.:

The Dow Treads Water as Pfizer, General Electric Struggle With Mergers in Europe
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 16, 11:30AM CDT
The  Dow Jones Industrials was down just four points as of 12:30 p.m. EDT Friday. Even after two days of sharp declines, investors aren't willing to dive in to buy the dips as they have in the past. As some investors focus on the latest disclosure...

Early Glance: Tools and Appliances companies
AP - Fri May 16, 10:47AM CDT
NEW YORK (AP) — Shares of some top tools and appliances companies are mixed at 10 a.m.:

Active Stocks Pre-Market Notes -- Research on Bank of America, Facebook, General Electric, and Petroleo Brasileiro
PR Newswire - Fri May 16, 8:20AM CDT
The markets on Thursday, May 15, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,446.81, down 1.01% and the NASDAQ Composite closed at 4,069.29, down 0.76%. The S&P 500 edged 0.94% lower, to finish the day at 1,870.85. The losses were broad based as nine out of ten sectors ended the session in negative. The losses in Financials, Energy and Materials sectors negatively impacted the market, while some positive momentum was observed in the Telecommunication Services sector. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Bank of America Corporation (NYSE: BAC), Facebook Inc. (NASDAQ: FB), General Electric Company (NYSE: GE) and Petroleo Brasileiro S.A. (NYSE: PBR). Free technical research on BAC, FB, GE and PBR can be downloaded upon signing up at:

Oppenheimer Concludes Its Ninth Annual Industrial Growth Conference in New York City May 13 and 14
PR Newswire - Fri May 16, 8:00AM CDT
Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings (NYSE: OPY), held its ninth annual Industrial Growth Conference in New York on May 13 and 14, 2014. The conference featured more than 60 leading public companies in the industrial growth sector, including FedEx Corp.; General Electric Co.; Honeywell International, Inc.; and Praxair, Inc. Institutional investors had the opportunity to attend company presentations as well as meet with company managements in group and one-on-one meetings.

Global Cell-Based Assays Market Report 2014-2018 Featuring Key Players, BD Biosciences, Danaher, DiscoveRx, EMD Millipore, GE Healthcare, Life Technologies, PerkinElmer, Corporation & Promega
M2 - Fri May 16, 2:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kcjpnl/cellbased_assays) has announced the addition of the "CGlobal Cell-Based Assays Market 2014-2018 Featuring BD Biosciences, Danaher Corporation, DiscoveRx, EMD Millipore, GE Healthcare, Life Technologies, PerkinElmer, Corporation & Promega" report to their offering. Cell-based assays offer a sensitive and reliable technology that facilitates live cell studies for various research-based and commercial applications. These assays are emerging as a preferred tool when compared to other competing methods such as animal tests and biochemical assays. Cell based assays are more cost and time effective and have higher throughput when compared with conventional animal tests. Also, they produce accurate results and present wider range of applications than the biochemical assays. These are the major factors driving the growth of market. The global cell-based assays market is segmented on the basis of products, applications, and end users. The products market is further subdivided into consumables (including reagents and assay kits, microplates and cell lines), instruments (detection and screening instruments such as microplate readers, flow cytometers, label-free detection instruments fluorescence microscopes, high content screening instruments and automation and high throughput screening instruments), software and cell based assay development services. Major types of cell based assays captured in the report include cell growth assays, cell death assays, second messenger assays and reporter gene assays. Based on applications, the cell based assays market is categorized into basic research, drug discovery, ADME, predictive toxicology and other applications. Drug discovery represents the largest share of amongst these applications. With rapid developments in fields such as cell biology, genomics, proteomics and bioinformatics, the number of potential drug candidates has risen significantly, and so have the drug discovery studies. Government initiatives and public-private partnerships along with drying drug pipeline in pharmaceutical industry have led to increase in drug discovery activities; which is stimulating the market growth. Presently, the market is all set to witness trends such as label free detection, drug discovery outsourcing, 3D culture and stem cells. However, the major hindrances to the growth of the market are high-cost associated with detection technologies and intellectual property issues for assay kits. Scope Market by Product - Reagents & Assay Kits (Cytotoxicity, GPCR) - Cell lines - Plate Readers - HCS - HTS - Software & Assay Development Services Market by Application - Drug Discovery - ADMET Market by End-user - Pharmaceutical - CRO Companies Mentioned - Becton, Dickinson and Company - Cell Signaling Technology - Cisbio Bioassays (Argos Soditic) - Danaher Corporation - Discoverx - EMD Millipore (A Subsidiary of Merck Kgaa) - Ge Healthcare (Subsidiary of General Electric Company) - Life Technologies (Thermo Fisher Scientific) - Perkinelmer, Inc. - Promega Corporation For more information visit http://www.researchandmarkets.com/research/kc...sed_assays

Baker Hughes Inc Continues to Outperform Its End Markets
Lee Samaha, The Motley Fool - Motley Fool - Thu May 15, 3:12PM CDT
Prospects for oil services company Baker Hughes are never really going to be divorced from the outlook for energy prices. However, the company has made great strides in operationally adjusting to flattish energy markets over the last year....

France Flexes Against General Electric's Bid For Alstom and General Motors Recall Tally Hits 18
Daniel Miller, The Motley Fool - Motley Fool - Thu May 15, 2:00PM CDT
The Dow Jones Industrial Average was trading 173 points lower, or 1%, by midafternoon even after the latest Labor Department reported that i nitial jobless claims fell sharply by 24,000 to a seasonally adjusted rate of 297,000 in the week ended...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 165

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 58

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 148

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 247

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 89

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading

Top 5 Most Recently Viewed Articles

Verizon Secures $66 Million EIS Partnership with Coast Guard

Updated Category News Views 283

Verizon Awarded $66 Million Enterprise Infrastructure Solutions Contract In a significant development, Verizon Business has been awarded a substantial contract valued at up to $66 million by the U.S. Coast Guard. This eight-year Enterprise Infrastructure Solutions (EIS) task order represents a robust commitment to enhancing the Coast Guard's communication and operational...

Continue Reading
Icelandic Glacial Becomes Laver Cup 2025's Official Water

Updated Category News Views 168

Icelandic Glacial to Hydrate Laver Cup 2025 Attendees Icelandic Glacial™, recognized for its exceptional quality and purity, has been designated as the Official Water for the highly anticipated Laver Cup 2025. This prestigious tournament is scheduled to take place at the Chase Center, showcasing top-tier men's tennis. A Perfect Fit for a Grand Event Coming from the...

Continue Reading
Dick's Sporting Goods Shows Promise for Q3 Amid Market Trends

Updated Category News Views 196

Dick's Sporting Goods Anticipates Strong Q3 Results Dick's Sporting Goods Inc. (NYSE: DKS) is gearing up for its fiscal third-quarter earnings report, creating buzz among investors eager to understand how the retailer is managing consumer demand and its recent strategic moves. As the company prepares to disclose its earnings, the market remains cautiously optimistic,...

Continue Reading
HyOrc Corporation Charts New Path with Green Fuel Innovations

Updated Category News Views 165

HyOrc Corporation's Strategic Market Transformation HyOrc Corporation (OTCID: HYOR) is making significant strides in the clean energy sector with a recent change in its trading symbol on the OTC markets. This evolution reflects not only a fresh identity but also the dynamic advancements the company is achieving in green fuel technologies and hydrogen mobility....

Continue Reading
Exploring Nature Through Art: BlackBook's New Exhibition

Updated Category News Views 227

BlackBook Presents Unveils a Unique Art Exhibition BlackBook Presents is set to embark on an exciting journey with its upcoming art exhibition titled Mother Nature in the Bardo. This innovative presentation, in collaboration with UNESCO's GEM Report, aims to foster meaningful discussions about art, culture, and their profound connection to environmental issues. Through an...

Continue Reading